Indivior
(NASDAQ:INDV)
$17.75
-0.12[-0.67%]
Last update: 12:43PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Indivior Stock (NASDAQ:INDV), Quotes and News Summary

Indivior Stock (NASDAQ: INDV) stock price, news, charts, stock research, profile.

Open$18.070
Close-
Volume / Avg.29.293K / 134.289K
Day Range17.660 - 18.130
52 Wk Range14.381 - 26.500
Market Cap$2.400B
P/E Ratio447.000
Dividend Yield-
ExchangeNASDAQ
RSI
39
Short Interest-
Days to Cover1.54

Recent News

Addiction Treatment Company, Indivior, Reports 12% YoY Growth For First Quarter Led By Sublocade Sales
Nina Zdinjak
This Nasal Spray Rapidly Reverses Effects Of Fentanyl Overdose And No, It's Not Naloxone
Indivior announced on Monday results from a pharmacodynamic study demonstrating that OPVEE rapidly reverses opioid-induced respiratory depression, the major cause of deaths due to opioid overdose. Titled "Reversal of opioid-induced respiratory depression in healthy volunteers: comparison of intranasal nalmefene and intranasal naloxone", the study was published in the Journal of Clinical Pharmacology. It was part of the OPVEE development program and reviewed by the FDA as part of the approval process. The research was focused on a head-to-head comparison examining the effects of 2.7 mg intranasal (IN) nalmefene (OPVEE) and 4 mg IN naloxone on opioid-induced respiratory depression. The findings showed that OPVEE reversed the respiratory depression produced by remifentanil – which is a synthetic opioid related to fentanyl - during the first 5 minutes following the administration.
Jelena Martinovic
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc.
Avi Kapoor
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
INDV
SUPN

FAQ

Q

How do I buy Indivior (INDV) stock?

A

You can purchase shares of Indivior (NASDAQ: INDV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Indivior's (INDV) competitors?

A

Other companies in Indivior’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).

Q

What is the target price for Indivior (INDV) stock?

A

The latest price target for Indivior (NASDAQ: INDV) was reported by Craig-Hallum on Wednesday, April 3, 2024. The analyst firm set a price target for 37.00 expecting INDV to rise to within 12 months (a possible 108.45% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Indivior (INDV)?

A

The stock price for Indivior (NASDAQ: INDV) is $17.75 last updated Today at May 14, 2024 at 12:43 PM EDT.

Q

Does Indivior (INDV) pay a dividend?

A

There are no upcoming dividends for Indivior.

Q

When is Indivior (NASDAQ:INDV) reporting earnings?

A

Indivior’s Q2 earnings are confirmed for Thursday, July 25, 2024.

Q

Is Indivior (INDV) going to split?

A

There is no upcoming split for Indivior.

Q

What sector and industry does Indivior (INDV) operate in?

A

Indivior is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch